Literature DB >> 17827710

PTEN: its deregulation and tumorigenesis.

Tomohiko Maehama1.   

Abstract

The tumor suppressor phosphatase and tensin homolog (PTEN) functions as a phosphoinositide 3-phosphatase, that antagonizes phosphatidylinositol 3-kinase action, and negatively regulates cell proliferation and survival signals. Inactivation of PTEN by loss-of-function mutations gives rise to deregulated hyperproliferation of cells, leading to oncogenic transformation. Recent studies have identified a number of upstream regulatory factors for PTEN and unveiled that the impairment in the PTEN regulatory system potentially becomes a causal factor for oncogenic transformation of cells. This article will review the PTEN inactivation mechanism which is linked to human tumorigenesis, particularly focusing on recent research progress in PTEN regulators.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17827710     DOI: 10.1248/bpb.30.1624

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  20 in total

1.  Lipid Signaling in Tumorigenesis.

Authors:  Renyan Liu; Ying Huang
Journal:  Mol Cell Pharmacol       Date:  2014-01-01

2.  Cycling exercise affects the expression of apoptosis-associated microRNAs after spinal cord injury in rats.

Authors:  Gang Liu; Benjamin E Keeler; Victoria Zhukareva; John D Houlé
Journal:  Exp Neurol       Date:  2010-09-16       Impact factor: 5.330

3.  Targeting PI3K/Akt/HSP90 signaling sensitizes gastric cancer cells to deoxycholate-induced apoptosis.

Authors:  Maria J Redlak; Thomas A Miller
Journal:  Dig Dis Sci       Date:  2010-06-29       Impact factor: 3.199

Review 4.  Autophagy as a therapeutic target in cancer.

Authors:  Ning Chen; Vassiliki Karantza
Journal:  Cancer Biol Ther       Date:  2011-01-15       Impact factor: 4.742

5.  Role of microRNA-21 and effect on PTEN in Kazakh's esophageal squamous cell carcinoma.

Authors:  Wen-Jing Ma; Guo-Dong Lv; Aerziguli Tuersun; Qing Liu; Hui Liu; Shu-Tao Zheng; Cong-Gai Huang; Jun-Guo Feng; Xing Wang; Ren-Yong Lin; Ilyar Sheyhidin; Xiao-Mei Lu
Journal:  Mol Biol Rep       Date:  2010-11-20       Impact factor: 2.316

6.  The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.

Authors:  Linda Zuurbier; Emanuel F Petricoin; Maartje J Vuerhard; Valerie Calvert; Clarissa Kooi; Jessica G C A M Buijs-Gladdines; Willem K Smits; Edwin Sonneveld; Anjo J P Veerman; Willem A Kamps; Martin Horstmann; Rob Pieters; Jules P P Meijerink
Journal:  Haematologica       Date:  2012-04-04       Impact factor: 9.941

Review 7.  Exploiting PI3K/mTOR signaling to accelerate epithelial wound healing.

Authors:  R M Castilho; C H Squarize; J S Gutkind
Journal:  Oral Dis       Date:  2013-02-04       Impact factor: 3.511

8.  Nuclear PTEN levels and G2 progression in melanoma cells.

Authors:  Abraham I Jacob; Todd Romigh; Kristin A Waite; Charis Eng
Journal:  Melanoma Res       Date:  2009-08       Impact factor: 3.599

9.  Cytogenetic and cDNA microarray expression analysis of MCF10 human breast cancer progression cell lines.

Authors:  Narasimharao V Marella; Kishore S Malyavantham; Jianmin Wang; Sei-ichi Matsui; Ping Liang; Ronald Berezney
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

10.  Phosphoinositide 3-kinase targeting by the beta galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death.

Authors:  Valerie Wells; Livio Mallucci
Journal:  Breast Cancer Res       Date:  2009-01-08       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.